Interferon-β-1a
Transcript of Interferon-β-1a
Reactions 1380 - 3 Dec 2011
SInterferon-β-1a
Thrombotic microangiopathy: case reportA 45-year-old man was diagnosed with relapsing-
remitting multiple sclerosis in 2004. He started receivingSC interferon-β-1a 44µg three times per week, inMarch 2005. In March 2006, proteinuria was first noticedat a flow of 0.2 g/24 hours. Two years later, proteinuriaincreased to 1.72 g/24 hours composed of 80% albumin. InJanuary 2010, renal biopsy revealed thromboticmicroangiopathy. He received treatment with an ACEinhibitor; however, proteinuria increased to 4 g/24 hours inDecember 2010. Relapse again occurred in March 2011,and interferon-β-1a was switched to glatiramer acetate. Attwo-month follow-up, proteinuria was decreasing.
Author comment: "The temporal association betweenproteinuria, interferon therapy’s institution and its arrest, isstriking and suggestive of a causal link."Bensa C, et al. A case of thrombotic microangiopathy associated withsubcutaneous beta-1a-interferon therapy. 27th Congress of the EuropeanCommittee for Treatment and Research in Multiple Sclerosis : abstr. P 526, 19 Oct2011. Available from: URL: http://link.adisinsight.com/r6H8C -France 803063664
1
Reactions 3 Dec 2011 No. 13800114-9954/10/1380-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved